Imophoron
Imophoron is the developer of a novel next-generation rapid-response vaccine platform, ADDomer(TM).
Bristol, UK
Total raised
€4.7M
€4,709,755
Funding rounds
1
Investors
3
distinct backers
Active since
2021-10
latest 2021-10
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood11
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-10-08 | Other | €4.7M | Dr Jonathan Milner,Octopus Ventures,Science Creates Ventures | View deal → |
Related news
- Imophoron Raises GBP 4M in Fundingfinsmes.com · 2021-10